Eczema

Clinics: Greater Manchester, Merseyside and West Yorkshire

Therapy Area: Atopic Dermatitis

Gender and Age: Males & Females aged 18 to 65

Reimbursement: Between £1200 and £1615

About The Research...

MAC Clinical Research is currently conducting a trial to test a new oral medication for eczema. Eczema, or atopic dermatitis, is a chronic inflammatory skin disorder and is the most common form of the condition, affecting up to 20% of the general population.

The purpose of this trial is to test how well study medication, EDP1867, works for the symptoms of eczema, and other long term immunoinflammatory conditions, and to see how safe and well tolerated it is.

The study will last approximately 14 weeks and consist of 12 outpatient visits at either of our Merseyside or West Yorkshire clinics, and either, 12 outpatient visits, or one 3-night residential stay and 9 outpatient visits at our Greater Manchester clinic.

If the study medication is effective you may benefit from an improvement in your disease, but there is no guarantee. It is possible that you may not personally benefit from your participation in this study. However, by taking part, you will provide new information that may benefit other patients in the future.

A full description of the study will be given before you decide to take part, both over the phone and during an appointment at a MAC clinic. This will include you receiving the full patient information sheet (PIS). Your GP will also be notified of your participation.

Reimbursement: Between £1200 and £1615

Criteria

Key Inclusion Criteria:

  • Male or female aged 18 – 65.
  • Diagnosis of eczema for at least the 6 months.
  • BMI 18 – 35 kg/m2

 

Key Exclusion Criteria:

  • Use of anti-inflammatory medications (such as ibuprofen) during the trial.
  • Use of methotrexate, steroids, ciclosporin or cyclophosphamide for eczema within 4 weeks of screening.
  • Use of topical medications that could affect eczema (for example steroid cream) two weeks prior and during the trial.

 

Other eligibility criteria will apply. Please contact MAC for more information.

Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.

MAC Clinical Research is conducting a trial to evaluate a potential new treatment for eczema.

If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • (You can enter any supporting information here)
Data Privacy Statement

Know someone who may be interested in taking part? Share this page here:

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on email
Email